Solid state forms of a pharmaceutical

Details for Australian Patent Application No. 2009231589 (hide)

Owner Harbor BioSciences, Inc.

Inventors Wolf, Brenton; Ivanisevic, Igor; White, Steven K.; Stephens, Kyle; Andres, Mark

Agent Griffith Hack

Pub. Number AU-A-2009231589

PCT Pub. Number WO2009/124300

Priority 61/042,240 03.04.08 US

Filing date 3 April 2009

Wipo publication date 8 October 2009

International Classifications

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07J 5/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom

Event Publications

25 November 2010 PCT application entered the National Phase

  PCT publication WO2009/124300 Priority application(s): WO2009/124300

7 April 2011 Alteration of Name

  The name of the applicant has been altered to Harbor BioSciences, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009231595-Registering multiple ophthalmic datasets

2009231588-Apparatus and methods for establishing client-host associations within a wireless network